Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D9J4ZI
|
|||
| Drug Name |
JNJ-64213175
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Respiratory syncytial virus infection [ICD-11: 1C80; ICD-9: 79.6] | Phase 1/2 | [1] | |
| Company |
Janssen
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03502707) A Study to Evaluate the Safety and Immunogenicity for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years and Older. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.